Management of High Anion Gap Metabolic Acidosis in CHF Patients on Aggressive Diuretic Therapy

Diagnostic Evaluation

Measure serum lactate immediately to confirm lactic acidosis as the cause of a high anion‑gap in patients with congestive heart failure receiving high‑dose diuretics. 1
Recognize that prerenal azotemia from volume depletion, reduced cardiac output due to excessive diuresis, and renal hypoperfusion are the principal mechanisms producing lactic acidosis in this population. 2

Systematically exclude ketoacidosis, uremic acidosis, and toxic ingestions (e.g., salicylates, ethylene glycol, methanol) when evaluating a high anion‑gap in these patients. 1

If volume depletion is identified, administer isotonic saline at 15–20 mL kg⁻¹ hr⁻¹ (≈1–1.5 L in the first hour) while closely monitoring for pulmonary edema. 1

When metolazone is used, perform frequent (e.g., daily) measurements of serum creatinine and electrolytes to detect azotemia and electrolyte disturbances. [4][5]6

Canadian cardiovascular guidelines advise against routine spironolactone in severe renal dysfunction (creatinine > 2.8 mg/dL) because of insufficient supporting evidence. 2
In CKD stage 3, initiate weekly potassium monitoring during the first month, then extend intervals as renal function stabilises, to mitigate hyper‑kalaemia risk. [7][8]
Discontinue spironolactone if serum creatinine rises > 50 % from baseline or exceeds 266 µmol/L (≈3.0 mg/dL). [2][8]
Hold or reduce spironolactone when serum potassium exceeds 5.5 mmol/L. [8][7]